Ceramides are a family of waxy lipid molecules composed of sphingosine and a fatty acid. They are key components of cell membranes and serve as bioactive signaling molecules that regulate apoptosis, inflammation, insulin resistance, and cellular stress responses.
Ceramides are synthesized de novo from palmitoyl-CoA and serine, or generated through sphingomyelin hydrolysis. They accumulate in response to saturated fat intake, inflammatory cytokines, and cellular stress. Elevated ceramides inhibit insulin signaling by blocking Akt phosphorylation, impair mitochondrial function, promote inflammation through NF-ÎșB activation, and trigger apoptosis in beta cells. Specific ceramide species (C16:0, C18:0, C24:1) are associated with cardiovascular disease and metabolic dysfunction.
Ceramides are emerging biomarkers for cardiovascular disease risk and metabolic dysfunction, independent of traditional lipid markers. Elevated ceramides predict heart attack, stroke, and death better than LDL cholesterol. They mediate the link between saturated fat intake, inflammation, and insulin resistance. Interventions that reduce ceramides (reducing saturated fat, increasing omega-3s, exercise, caloric restriction) improve metabolic health. Measuring specific ceramide ratios may guide personalized cardiovascular risk assessment and treatment.
- Waxy lipid molecules composed of sphingosine and fatty acid
- Bioactive signaling molecules regulating apoptosis and inflammation
- Accumulate in response to saturated fat, cytokines, and stress
- Inhibit insulin signaling by blocking Akt phosphorylation
- Impair mitochondrial function and promote beta cell apoptosis
- Specific species (C16:0, C18:0, C24:1) associated with CVD
- Predict cardiovascular events better than LDL cholesterol
- Reduced by omega-3s, exercise, caloric restriction
- insulin resistance â ceramides cause insulin resistance by inhibiting Akt signaling pathway
- Saturated Fatty Acids â saturated fat intake increases ceramide synthesis
- Omega-3 fatty acids â omega-3s reduce ceramide levels and improve insulin sensitivity
- inflammation â ceramides promote inflammation through NF-ÎșB activation
- NF-ÎșB â ceramides activate NF-ÎșB inflammatory signaling pathway
- Mitochondria â ceramides impair mitochondrial function and promote dysfunction
- apoptosis â ceramides trigger programmed cell death, especially in beta cells
- Type 2 Diabetes â elevated ceramides contribute to beta cell death and insulin resistance in diabetes
- cardiovascular disease â ceramides are independent predictors of CVD risk
- LDL â ceramides predict CVD better than traditional LDL cholesterol
- AKT pathway â ceramides block Akt phosphorylation, impairing insulin signaling
- sphingolipids â ceramides are central molecules in sphingolipid metabolism
- cell membranes â ceramides are structural components of cell membranes
- exercise â exercise reduces ceramide accumulation and improves metabolic health
- caloric restriction â caloric restriction reduces ceramide levels
- obesity â obesity associated with elevated ceramide levels
- Metabolic syndrome â ceramides are mechanistic link between obesity, insulin resistance, and CVD in metabolic syndrome
- beta-cell stress hypothesis â ceramide accumulation in beta cells drives apoptosis in diabetes
- Lipotoxicity â ceramides mediate lipotoxic damage to cells from excess lipid accumulation
- biomarkers â ceramide ratios are emerging biomarkers for personalized CVD risk